Healthcare / Medical Care FacilitiesNYSE
$29.34
+0.37 (+1.28%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 24% · confianza 25%
FCF escenarios
weak_data · normalized FCF $239.5M · quality 61.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
33/100
D
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$1.1B
P/E
N/A
•EV/EBITDA
18.8x
↑ROE
-14.9%
↓Gross Margin
28.3%
↓Debt/Equity
1.25
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2009–2025 · 16 años de histórico normalizado
Revenue CAGR
+8.3%
FCF CAGR
+5.8%
FCF margin
8.6%
FCF / Net income
-2.44x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $2.73B · net income $-95.7M · FCF $233.8M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||||||
| Revenue | $2.73B | $2.73B | $2.98B | $3.79B | $5.24B | $3.98B | $2.39B | $2.22B | $2.14B | $1.99B | $1.90B | $1.46B | $1.04B | $1.01B | $954.0M | $887.5M | $669.9M | $759.8M |
| Net Income | $-95.7M | $-95.7M | $-147.0M | $210.7M | $444.1M | $327.4M | $70.7M | $114.0M | $141.7M | $132.6M | $105.8M | $81.9M | $33.2M | $32.9M | $17.1M | $-26.3M | $-52.0M | $-122.2M |
| EBITDA | $101.1M | $101.1M | $71.1M | $499.4M | $784.2M | $581.7M | $243.5M | $235.4M | $244.1M | $244.7M | $221.3M | $149.8M | $83.9M | $79.0M | $67.5M | $54.0M | $-29.0M | $-139.8M |
| EPS | -2.48 | -2.48 | -3.85 | 5.36 | 9.90 | 6.81 | 1.48 | 2.40 | 2.91 | 2.68 | 2.15 | 1.68 | 0.69 | 0.69 | 0.37 | -0.57 | -1.49 | -3.75 |
| Gross Margin | 28.3% | 28.3% | 30.8% | 33.0% | 32.7% | 32.9% | 33.1% | 33.5% | 32.6% | 32.4% | 32.6% | 32.1% | 30.5% | 29.4% | 28.3% | 28.1% | 27.5% | 26.9% |
| Operating Margin | 1.2% | 1.2% | 4.0% | 9.1% | 12.3% | 12.0% | 6.2% | 8.0% | 9.5% | 10.7% | 10.1% | 8.8% | 6.6% | 6.5% | 5.6% | 4.2% | -6.5% | -20.2% |
| Net Margin | -3.5% | -3.5% | -4.9% | 5.6% | 8.5% | 8.2% | 3.0% | 5.1% | 6.6% | 6.7% | 5.6% | 5.6% | 3.2% | 3.3% | 1.8% | -3.0% | -7.8% | -16.1% |
| Balance Sheet | ||||||||||||||||||
| Debt/Equity | 1.25 | 1.25 | 1.55 | 1.62 | 0.82 | 0.72 | 1.05 | 0.84 | 0.69 | 0.57 | 0.80 | 0.52 | 0.56 | 0.68 | 0.87 | 1.28 | — | — |
| Current Ratio | 1.09 | 1.09 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cash Flow | ||||||||||||||||||
| Free Cash Flow | $233.8M | $233.8M | $239.5M | $266.8M | $572.8M | $251.8M | $219.1M | $189.6M | $191.8M | $134.0M | $112.0M | $29.3M | $8.5M | $51.1M | $52.9M | $14.7M | $3.9M | $94.9M |
| Returns | ||||||||||||||||||
| ROE | -14.9% | -14.9% | -20.8% | 25.3% | 42.5% | 28.2% | 8.6% | 15.5% | 22.2% | 23.6% | 23.6% | 23.5% | 12.9% | 15.1% | 9.4% | -19.4% | -33.9% | -71.5% |
| Valuation | ||||||||||||||||||
| P/E | — | — | — | 13.83 | 11.09 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EV/EBITDA | 18.78 | 18.78 | 28.96 | 8.48 | 7.30 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| P/B | 1.76 | 1.76 | 1.38 | 3.51 | 4.72 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Growth & Yield | ||||||||||||||||||
| Revenue Growth | -8.5% | -8.5% | -21.3% | -27.7% | — | 66.4% | 7.7% | 4.0% | 7.4% | 4.5% | 30.0% | 41.2% | 2.4% | 6.1% | 7.5% | 32.5% | -11.8% | — |
| EPS Growth | 35.6% | 35.6% | -171.8% | -45.9% | — | 360.1% | -38.3% | -17.5% | 8.6% | 24.7% | 28.0% | 143.5% | 0.0% | 86.5% | 164.9% | 61.7% | 60.3% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+39.0%
Start / end P/E
n/dx → n/dx
EPS bridge
-3.85 → -2.48
Residual
+39.0%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.